By Daniel R. Matlis
To determine the industry’s adoption of a Total Product Life Cycle approach, as advocated by FDA, Axendia, in cooperation with Cambashi and FDAnews recently conducted a major research project on this subject.
A total of 212 industry insiders from a wide range of medical device and diagnostic companies participated in this research.
The research is now complete and the full findings are available in a new report entitled, “Total Product Lifecycle Management: Lowering Costs while Increasing Quality.”
We hope this research will serve as an aid to enable Medical Device companies in their transformation to a holistic end-to-end Total Product Lifecycle (TPLC) strategy.
The research is co-sponsored by five companies – all of which are active in the Medical Device industry. These companies provide deep and diverse expertise in medical devices practices and provide design, product lifecycle management, production, quality, and related software and services to the industry as well as management consulting services to leverage applications appropriately. Working together, these underwriting sponsors hope to increase the medical device market’s understanding of how to reduce risks and improve compliance and profitability.
Research Sponsors for the study are: management and technology consulting firm PricewaterhouseCoopers LLP (www.pwc.com/pharma), enterprise manufacturing and quality software provider Camstar Systems (www.camstar.com ), product lifecycle management (PLM) software innovator Dassault Systèmes Enovia (www.3ds.com) with its medical device industry PLM partner Integware (www.integware.com), and PLM and enterprise content management software provider PTC (www.ptc.com).
The analysis and report was prepared by Axendia and Cambashi, which retain full editorial control.